EUVIMEDEUVIMED entdecken
Crossref

Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Hydrops MR Imaging: Comparison in Contralateral Clinically Unaffected Ears

Anja Bernaerts, Floris Wuyts, Cathérine Blaivie, Joost van Dinther, Andrzej Zarowski, Kathleen Dhont, Caroline Venstermans, Filip Deckers, Bert De Foer

American Journal of Neuroradiology · 17.11.2026 · ajnr.A9719

DOI: 10.3174/ajnr.a9719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Neuroradiology, online erschienen am 17.11.2026. Verfasst von Anja Bernaerts und 8 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology (A.B., K.D., C.V., F.D., B.D.F.), ZAS Augustinus, Antwerp, Belgium; Faculty of Science (A.B., F.W.), Lab for Equilib….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Hydrops MR imaging, performed 4 hours after IV gadolinium administration, requires sufficient contrast-agent accumulation in the perilymph to delineate the nonenhancing endolymphatic spaces. The higher relaxivity of gadopiclenol may reduce gadolinium exposure while preserving perilymphatic enhancement and anatomic detail. Clinically unaffected contralateral reference ears provide a standardized reference that minimizes disease-related confounding. We compared half-dose gadopiclenol (0.05 mmol/kg; half the gadolinium dose) with full-dose gadobutrol (0.1 mmol/kg) for hydrops MR imaging. MATERIALS AND METHODS: This retrospective study reviewed 90 consecutive patients referred for hydrops MR imaging. Forty-five received gadobutrol (1.0 mmol/mL; 0.1 mmol/kg), and 45 received gadopiclenol (0.5 mmol/mL; 0.05 mmol/kg). Two experienced head and neck radiologists, blinded to clinical findings and contrast agent, independently evaluated the clinically unaffected reference ear. Quantitative endpoints were the signal intensity ratio (SIR) and reference-normalized contrast (RNC); qualitative endpoints were separate delineation of the saccule and utricle and visibility of the 3 semicircular canal ampullae. The prespecified noninferiority margin was 0.5 units, with a sensitivity analysis using 0.25 units. RESULTS: Seventy-one patients were included: 37 received gadopiclenol and 34 received gadobutrol. Nineteen were excluded because of motion degradation, suspected bilateral disease, or abnormal audiometric or MR imaging findings in the reference ear. Mean reader-averaged SIR was 8.15 (SD, 1.51) with gadopiclenol and 7.59 (SD, 1.40) with gadobutrol, yielding a mean difference of 0.56 (95% CI, -0.13 to 1.25). Mean reader-averaged RNC was 7.66 (SD, 1.56) and 6.97 (SD, 1.37), respectively, yielding a mean difference of 0.69 (95% CI, 0.00 to 1.39). Both lower confidence limits exceeded the noninferiority boundary of -0.5; noninferiority was maintained using -0.25. Interreader reliability was excellent for SIR (ICC, 0.915; 95% CI, 0.868-0.946) and RNC (ICC, 0.925; 95% CI, 0.882-0.952). Qualitative assessments showed no significant between-group differences. Where estimable, Cohen κ ranged from 0.66 to 1.00; observed agreement was 97.2%-100% for features with nonestimable κ. CONCLUSIONS: In clinically unaffected reference ears, gadopiclenol at 0.05 mmol/kg provides quantitative perilymphatic enhancement noninferior to that of gadobutrol at 0.1 mmol/kg, with comparable qualitative anatomic delineation. Higher-relaxivity gadopiclenol may therefore reduce gadolinium exposure without compromising reference-ear image quality.

Autor:innen und Institutionen

  • From the Department of Radiology (A.B., K.D., C.V., F.D., B.D.F.), ZAS Augustinus, Antwerp, Belgium; Faculty of Science (A.B., F.W.), Lab for Equilibrium Investigations and Aerospace (F.W.), University of Antwerp, Antwe…

Zitieren

APA

Bernaerts, A., Wuyts, F., Blaivie, C., van Dinther, J., Zarowski, A., Dhont, K., Venstermans, C., Deckers, F., & De Foer, B. (2026). Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Hydrops MR Imaging: Comparison in Contralateral Clinically Unaffected Ears. American Journal of Neuroradiology, ajnr.A9719. https://doi.org/10.3174/ajnr.a9719

Vancouver

Bernaerts A, Wuyts F, Blaivie C, van Dinther J, Zarowski A, Dhont K, et al. Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Hydrops MR Imaging: Comparison in Contralateral Clinically Unaffected Ears. American Journal of Neuroradiology. 2026:ajnr.A9719. doi:10.3174/ajnr.a9719

BibTeX
@article{Bernaerts2026,
  author = {Bernaerts, Anja and Wuyts, Floris and Blaivie, Cathérine and van Dinther, Joost and Zarowski, Andrzej and Dhont, Kathleen and Venstermans, Caroline and Deckers, Filip and De Foer, Bert},
  title = {Half-Dose Gadopiclenol versus Full-Dose Gadobutrol for Hydrops MR Imaging: Comparison in Contralateral Clinically Unaffected Ears},
  journal = {American Journal of Neuroradiology},
  year = {2026},
  pages = {ajnr.A9719},
  doi = {10.3174/ajnr.a9719}
}
Kostenlos starten →